Copyright: ©Author(s) 2026.
World J Gastroenterol. Mar 21, 2026; 32(11): 114243
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.114243
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.114243
Figure 4 Dietary energy consumption among participants with metabolically dysfunction-associated steatotic liver disease and healthy controls.
MASLD: Metabolically dysfunction-associated steatotic liver disease; MUFA: Monounsaturated fatty acid; PUFA: Polyunsaturated fatty acid.
- Citation: Hegazy M, Fathy M, Ashoush O, Abdelshafy S, Abdelfatah D, Saad S, Abd El-Moniem S, Ibrahim W, Ashraf O, Saleh S, Ahmed T, Adly R, Abdel-Wahab A, Ahmed A, Hussein S, Othman A, Abdelghani A. Egypt’s metabolic dysfunction associated steatotic liver disease: Genetic and dietary nexus, shaping artificial intelligence driven healthier future. World J Gastroenterol 2026; 32(11): 114243
- URL: https://www.wjgnet.com/1007-9327/full/v32/i11/114243.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i11.114243